Pancreatic Cancer Research

ResearcherAlbert Einstein College of MedicineActive in the last 2 years

Haejin In

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3267-6585; OpenAlex author ID A5058170305. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. CA19-9 Benefits Prognostication of Pancreatic Cancer: Is It Time to Add CA19-9 to Its Staging Criteria? First author DOI 10.1245/s10434-024-15321-w↗
  2. Pancreatic Cancer Surgery Following Emergency Department Admission: Understanding Poor Outcomes and Disparities in Care. Last author DOI 10.1007/s11605-020-04614-6↗
  3. Research gaps in pancreatic cancer research and comparative effectiveness research methodologies. Co-author DOI 10.1007/978-3-319-12553-4_10↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiang Gao · 1 shared paper, 2024 · strength 0.46
  2. John Christopher McAuliffe · 1 shared paper, 2021 · strength 0.17
  3. Vishes V. Mehta · 1 shared paper, 2021 · strength 0.17
  4. Peter Muscarella Md · 1 shared paper, 2021 · strength 0.17
  5. Mitchell C. Posner · 1 shared paper, 2015 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.